Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInterest Coverage RatioNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

InflaRx (IFRX) Return on Capital Employed (2022 - 2025)

Historic Return on Capital Employed for InflaRx (IFRX) over the last 4 years, with Q3 2025 value amounting to 0.87%.

  • InflaRx's Return on Capital Employed fell 900.0% to 0.87% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.87%, marking a year-over-year decrease of 900.0%. This contributed to the annual value of 0.63% for FY2024, which is 1500.0% down from last year.
  • According to the latest figures from Q3 2025, InflaRx's Return on Capital Employed is 0.87%, which was down 900.0% from 0.81% recorded in Q2 2025.
  • In the past 5 years, InflaRx's Return on Capital Employed ranged from a high of 0.1% in Q1 2023 and a low of 0.87% during Q3 2025
  • In the last 4 years, InflaRx's Return on Capital Employed had a median value of 0.52% in 2024 and averaged 0.52%.
  • As far as peak fluctuations go, InflaRx's Return on Capital Employed crashed by -500bps in 2023, and later tumbled by -5500bps in 2024.
  • Quarter analysis of 4 years shows InflaRx's Return on Capital Employed stood at 0.27% in 2022, then dropped by -17bps to 0.32% in 2023, then tumbled by -161bps to 0.83% in 2024, then decreased by -5bps to 0.87% in 2025.
  • Its Return on Capital Employed was 0.87% in Q3 2025, compared to 0.81% in Q2 2025 and 0.83% in Q1 2025.